Efficacy of ApoC-II Mimetic Peptide in Novel Apoc2 Mutant Mice With Hypertriglyceridemia and Impaired Insulin Sensitivity

被引：0
|
作者：
Sakurai, Toshihiro
Sakurai, Akiko
Vaisman, Boris L.
Amar, Marcelo J.
Liu, Chengyu
Gordon, Scott M.
Drake, Steven K.
Pryor, Milton
Sampson, Maureen L.
Yang, Ling
Freeman, Lita A.
Noguchi, Audrey
Remaley, Alan T.
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2016年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A430
引用
收藏
页数：2
相关论文
共 13 条
  • [1] Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptides
    Sakurai, Toshihiro
    Sakurai, Akiko
    Vaisman, Boris L.
    Amar, Marcelo J.
    Liu, Chengyu
    Gordon, Scott M.
    Drake, Steven K.
    Pryor, Milton
    Sampson, Maureen L.
    Yang, Ling
    Freeman, Lita A.
    Remaley, Alan T.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 356 (02): : 341 - 353
  • [2] ApoC-II Mimetic Peptide Blunts Post-Prandial Hypertriglyceridemia in Mice
    Wolska, Anna
    Sakurai, Toshihiro
    Sviridov, Denis
    Pryor, Milton
    Lo, Larry
    Ghosh, Soumitra
    Devalaraja, Madhav
    Remaley, Alan T.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [3] A DUAL APOC-II MIMETIC - APOC-III ANTAGONIST PEPTIDE AS A POTENTIAL TREATMENT FOR HYPERTRIGLYCERIDEMIA
    Wolska, A.
    Sviridov, D.
    Pourmousa, M.
    Pastor, R.
    Pryor, M.
    Wilson, S.
    Lo, L.
    Ghosh, S.
    Davidson, M.
    Devalaraja, M.
    Goldberg, I.
    Basu, D.
    Freeman, L.
    Amar, M.
    Neher, S.
    Wu, M. J.
    Tang, J.
    Drake, S.
    Cougnoux, A.
    Remaley, A. T.
    ATHEROSCLEROSIS, 2021, 331 : E123 - E124
  • [4] A Dual apoC-II mimetic-apoC-III Antagonist Peptide for Lowering Plasma Triglycerides
    Wolska, Anna
    Lo, Larry
    Sviridov, Denis O.
    Pourmousa, Mohsen
    Pryor, Milton
    Ghosh, Soumitra S.
    Kakkar, Rahul
    Davidson, Michael
    Wilson, Sierra
    Pastor, Richard W.
    Tang, Jingrong
    Amar, Marcelo
    Devalaraja, Matt
    Remaley, Alan T.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39
  • [5] APOC-IIPARIS2 - A PREMATURE TERMINATION MUTATION IN THE SIGNAL PEPTIDE OF APOC-II RESULTING IN THE FAMILIAL CHYLOMICRONEMIA SYNDROME
    PARROTT, CL
    ALSAYED, N
    REBOURCET, R
    SANTAMARINAFOJO, S
    JOURNAL OF LIPID RESEARCH, 1992, 33 (03) : 361 - 367
  • [6] A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis
    Jiang, Jingjing
    Wang, Yuhui
    Ling, Yan
    Kayoumu, Abudurexiti
    Liu, George
    Gao, Xin
    LIPIDS IN HEALTH AND DISEASE, 2016, 15
  • [7] A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis
    Jingjing Jiang
    Yuhui Wang
    Yan Ling
    Abudurexiti Kayoumu
    George Liu
    Xin Gao
    Lipids in Health and Disease, 15
  • [8] Erratum to: A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis
    Jingjing Jiang
    Yuhui Wang
    Yan Ling
    Abudurexiti Kayoumu
    George Liu
    Xin Gao
    Lipids in Health and Disease, 15
  • [9] A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis (vol 15, pg 12, 2016)
    Jiang, Jingjing
    Wang, Yuhui
    Ling, Yan
    Kayoumu, Abudurexiti
    Liu, George
    Gao, Xin
    LIPIDS IN HEALTH AND DISEASE, 2016, 15
  • [10] A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis
    Ueda, Masako
    Dunbar, Richard L.
    Wolska, Anna
    Sikora, Tracey U.
    Escobar, Maria del Rosario
    Seliktar, Naomi
    deGoma, Emil
    DerOhannessian, Stephanie
    Morrell, Linda
    McIntyre, Adam D.
    Burke, Frances
    Sviridov, Denis
    Amar, Marcelo
    Shamburek, Robert D.
    Freeman, Lita
    Hegele, Robert A.
    Remaley, Alan T.
    Rader, Daniel J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (05): : 1454 - 1457
12